Jonathan T. Yang, MD, PhD, has been appointed affiliate vice chair for medical analysis and developmental therapeutics within the division of radiation oncology at NYU Langone Well being’s Perlmutter Most cancers Middle.
Yang additionally will function director of the metastatic illness service within the division of radiation oncology, in addition to director of medical analysis on the Mind and Backbone Tumor Middle.
“I’m honored to hitch NYU Langone’s Perlmutter Most cancers Middle, the place we’ve so many devoted clinicians and researchers already doing nice work within the area of metastatic illness,” Yang stated in a press launch. “Collaborating with this staff will permit us all to be taught extra, and in the end create simpler and safer therapies that profit our sufferers.”
Yang’s medical and analysis focus has been on bettering remedy for sufferers with metastatic most cancers. His work has targeted on leptomeningeal illness, a type of metastasis within the skinny layers of tissue and fluid that cowl the spinal twine and mind.
In his function on the Mind and Backbone Tumor Middle, Yang will collaborate with a multidisciplinary staff to supply remedy for mind tumors, together with gliomas, astrocytomas, major central nervous system lymphoma, pituitary adenoma and metastatic mind tumors.
Yang beforehand held college and management positions at Memorial Sloan Kettering Most cancers Middle and College of Washington College of Medication.
“Dr. Yang brings a powerful wealth of expertise and experience to our staff, and we’re lucky to have him be part of us,” Alec Kimmelman, MD, PhD, Anita Steckler and Joseph Steckler chair of radiation oncology and director of Perlmutter Most cancers Middle, stated within the launch. “I’m assured that Dr. Yang will contribute considerably to the continued success within the fields of radiation oncology and mind and backbone tumor care.”
